HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(+)-Magnolin Enhances Melanogenesis in Melanoma Cells and Three-Dimensional Human Skin Equivalent; Involvement of PKA and p38 MAPK Signaling Pathways.

Abstract
Magnoliae Flos is a traditional herbal medicine used to treat nasal congestion associated with headache, empyema, and allergic rhinitis. In our preliminary screening of crude drugs used in Japanese Kampo formulas for melanin synthesis, the methanol extract of Magnoliae Flos was found to exhibit strong melanin synthesis activity. However, there have been no studies evaluating the effects of Magnoliae Flos or its constituents on melanogenesis. The present study aimed to isolate the active compounds from Magnoliae Flos that activate melanin synthesis in melanoma cells and three-dimensional human skin equivalent, and to investigate the molecular mechanism underlying melanin induction. The methanol extract of Magnoliae Flos induced an increase of melanin content in both B16-F1 and HMV-II cells. A comparison of melanin induction by three fractions prepared from the extract showed that the ethyl acetate fraction markedly induced melanin synthesis. Bioassay-guided separation of the ethyl acetate fraction resulted in the isolation of seven lignans (1:  - 7: ). Among them, (+)-magnolin (5: ) strongly induced melanin synthesis and intracellular tyrosinase activity. Furthermore, the ethyl acetate fraction and 5: clearly induced melanin content in a three-dimensional human skin equivalent. Molecular analysis revealed that 5: triggered the protein expression of tyrosinase, tyrosinase-related protein-1, and tyrosinase-related protein-2. Further analysis of transcriptional factors and signaling pathways demonstrated that 5: induces the protein expression of tyrosinase, tyrosinase-related protein-1, and tyrosinase-related protein-2 activated by the protein kinase A- and p38 mitogen-activated protein kinase-dependent pathways, leading to cAMP-responsive element-binding protein phosphorylation and microphthalmia-associated transcription factor expression. These findings demonstrate the potential of 5: as a potent therapeutic agent for hypopigmentation.
AuthorsTakuhiro Uto, Nguyen Huu Tung, Tomoe Ohta, Yukihiro Shoyama
JournalPlanta medica (Planta Med) Vol. 88 Issue 13 Pg. 1199-1208 (Oct 2022) ISSN: 1439-0221 [Electronic] Germany
PMID35211932 (Publication Type: Journal Article)
CopyrightThieme. All rights reserved.
Chemical References
  • Microphthalmia-Associated Transcription Factor
  • Melanins
  • ethyl acetate
  • Monophenol Monooxygenase
  • magnolin
  • Methanol
  • Cyclic AMP-Dependent Protein Kinases
  • Lignans
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Humans
  • Animals
  • Microphthalmia-Associated Transcription Factor (metabolism)
  • Melanins (metabolism, pharmacology)
  • Monophenol Monooxygenase
  • Methanol
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Lignans (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)
  • Signal Transduction
  • Melanoma (drug therapy, metabolism)
  • Melanoma, Experimental (drug therapy)
  • Cell Line, Tumor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: